Guizhou Xinbang Pharmaceutical News and Activities

Guizhou Xinbang Pharmaceutical is a company listed under the stock ticker 002390 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at Guizhou Xinbang Pharmaceutical

• Lingzhong Kong, General Manager
• Ji An, Chairman of the Board
• Gang Qiu, Independent Director

Create your alert
to follow the executive moves at Guizhou Xinbang Pharmaceutical.

Guizhou Xinbang Pharmaceutical has 1,919 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Catalyst Pharmaceuticals, listed under ticker CPRX, has been delisted. (posted on July 13 2026).
• Angelini Pharma has acquired Catalyst Pharmaceuticals (posted on July 13 2026).
• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Guizhou Xinbang Pharmaceutical

• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• View more press releases Close

Social media about Guizhou Xinbang Pharmaceutical

• Guizhou Xinbang Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Guizhou Xinbang Pharmaceutical on LinkedIn, X (Twitter) & YouTube